Summary Comments
- Most frequently detected viruses across all age groups during July:
- Rhino/Enterovirus: 27.5%
- Rhinovirus: 24.3%
- Metapneumovirus: 11%
- Epidemiological Week 1–30:
- SARS-CoV-2: Stable, with 6% positivity in week 30
- RSV A&B: Stable, 4.5% positivity in week 30
- Influenza A: Decreasing, 2.3% positivity in week 30
Respiratory Viral Multiplex PCR and SARS-CoV-2 PCR: All Age Groups
June 2023:
- Rhino/Enterovirus: 23.6%
- Rhinovirus: 20.5%
- Metapneumovirus: 11%
- SARS-CoV-2: 6.9%
- RSV: 4.5%
- Adenovirus: 2.7%
- Parainfluenza 1-4: 6.8%
- Influenza A: 4.0%
- Influenza B: 0.1%
July 2023:
- Rhino/Enterovirus: 27.5%
- Rhinovirus: 24.3%
- Metapneumovirus: 11%
- SARS-CoV-2: 4.3%
- RSV: 4.4%
- Adenovirus: 3.7%
- Parainfluenza 1-4: 5.4%
- Influenza A: 2.7%
- Influenza B: 0.1%
SARS-CoV-2, Influenza A, and RSV Positivity per Week (Weeks 1–30)
- SARS-CoV-2: Peaked at 45.4% (week 1), declined to 6% (week 30)
- Influenza A: Decreased steadily from 43% (week 2) to 2.3% (week 30)
- RSV: Fluctuated, 4.5% in week 30
Atypical Bacterial Pathogens (Week 1–30)
Total Cases:
- Bordetella pertussis: 386 cases
- Bordetella parapertussis: 23 cases
- Mycoplasma pneumoniae: 1006 cases (peak: week 25, 72 cases)
Age Distribution – B. pertussis:
- 0–6 months: 25%
- 6–12 years: 23%
- 1–5 years: 22%
18 years: 21%
Age Distribution – M. pneumoniae:
- 1–5 years: 40%
- 6–12 years: 28%
- 19–64 years: 15%
Weekly Case Counts (selected):
B. pertussis:
8, 7, 5, 16, 13, 4, 6, 8, 9, 9, 7, 11, 16, 10, 15, 19, 13, 13, 17, 9, 13, 23, 21, 11, 16, 13, 17, 9, 21, 27
B. parapertussis:
0, 1, 0, 2, 3, 2, 2, 1, 0, 1, 2, 2, 1, 0, 2, 0, 1, 0, 0, 1, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0
M. pneumoniae:
4, 6, 10, 7, 5, 11, 12, 17, 12, 18, 25, 30, 23, 34, 37, 36, 34, 42, 42, 52, 46, 63, 62, 57, 72, 48, 57, 53, 45, 46
Paediatric Respiratory Viral Multiplex PCR Data (Ages 0–12)
<1 Year Age Group
June 2023:
- Rhino/Enterovirus: 37.3%
- Rhinovirus: 35.8%
- Metapneumovirus: 16%
- RSV A&B: 13.5%
- Parainfluenza 1-4: 12.1%
- Adenovirus: 4.7%
- SARS-CoV-2: 3.4%
- Influenza A: 7.1%
- Influenza B: 0%
July 2023:
- Rhino/Enterovirus: 40.9%
- Rhinovirus: 31.8%
- Metapneumovirus: 16%
- RSV A&B: 11.2%
- Parainfluenza 1-4: 10.9%
- Adenovirus: 4.5%
- SARS-CoV-2: 1%
- Influenza A: 3.6%
- Influenza B: 0%
1–5 Year Age Group
June 2023:
- Rhino/Enterovirus: 39%
- Rhinovirus: 30.3%
- Metapneumovirus: 14%
- Adenovirus: 11%
- RSV A&B: 10.2%
- SARS-CoV-2: 4.3%
- Influenza A: 7.6%
- Influenza B: 0%
July 2023:
- Rhino/Enterovirus: 46%
- Rhinovirus: 39%
- Metapneumovirus: 14%
- Adenovirus: 18.2%
- RSV A&B: 5.1%
- SARS-CoV-2: 5.8%
- Influenza A: 5.2%
- Influenza B: 0.2%
6–12 Year Age Group
June 2023:
- Rhino/Enterovirus: 33%
- Rhinovirus: 24.5%
- RSV A&B: 2.4%
- Adenovirus: 5.5%
- SARS-CoV-2: 1.2%
- Influenza A: 2.2%
- Influenza B: 0.4%
July 2023:
- Rhino/Enterovirus: 33%
- Rhinovirus: 24.6%
- RSV A&B: 1.6%
- Adenovirus: 6.2%
- SARS-CoV-2: 0.5%
- Influenza A: 1.4%
- Influenza B: 0.4%
Continue Reading